Ipca Labs

{
  "main_header": {
    "sid": 950228,
    "name": "Ipca Labs",
    "stock_name": "Ipca Labs",
    "full_name": "Ipca Laboratories Ltd",
    "name_url": "stocks-analysis/ipca-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,584.10",
    "chg": 39.9,
    "chgp": "2.58%",
    "dir": 1,
    "prev_price": "1,544.20",
    "mcapval": "40,149.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": "524494",
    "symbol": "IPCALAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE571A01038",
    "curr_date": "Jun 19, 03:30 PM",
    "curr_time": "23:52 PM",
    "last_traded_at": "Jun 19, 03:30 PM IST",
    "bse_nse_vol": "3.23 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 19, 2026",
    "traded_date_str": "2026 06 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Ipca Laboratories Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-buy-4065083",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IpcaLaboratorie_mojoScore_4065083.png",
        "date": "2026-06-20 10:10:29",
        "description": "Ipca Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 8 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 20 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Ipca Laboratories Gains 8.60%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-860-5-key-factors-driving-the-weeks-momentum-4052100",
        "imagepath": "",
        "date": "2026-06-13 16:24:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Downgrade to Hold amid mixed technical and valuation signals</p>\n                    <p><strong>2 June:</strong> Valuation shifts to fair relative to sector peers</p>\n                    <p><strong>3 June:</strong> Technical momentum shifts to mildly bullish stance</p>\n                    <p><strong>4 June:</strong> Strong price gains on heavy volume (+4.23%)</p>\n                    <p><strong>5 June:</strong> Week closes at ₹1,643.05, up 8.60% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,512.90</div></div>\n            ..."
      },
      {
        "title": "Ipca Laboratories Declines 3.48% Despite Technical Upgrade: 5 Key Insights",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-declines-348-despite-technical-upgrade-5-key-insights-4051180",
        "imagepath": "",
        "date": "2026-06-13 11:05:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> MarketsMOJO upgrades Ipca Laboratories Ltd to Buy on strong technical and financial performance</p>\n                    <p><strong>9 June:</strong> Technical momentum shifts signal bullish outlook amid price near 52-week high</p>\n                    <p><strong>11 June:</strong> Heavy volume selling leads to 1.30% price decline</p>\n                    <p><strong>12 June:</strong> Week closes at ₹1,585.80, down 3.48% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹1,643.05</div></div>\n                    <div class=\"stat-item\"><..."
      },
      {
        "title": "Ipca Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4040512",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IpcaLaboratorie_mojoScore_4040512.png",
        "date": "2026-06-09 08:50:00",
        "description": "Ipca Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial metrics, valuation, and overall quality. This upgrade, effective from 8 June 2026, is underpinned by robust quarterly results, bullish technical trends, and favourable long-term returns that outpace the broader market."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4040170",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IpcaLaboratorie_technicaldot_4040170.png",
        "date": "2026-06-09 08:03:11",
        "description": "Ipca Laboratories Ltd has demonstrated a notable shift in technical momentum, upgrading its trend from mildly bullish to bullish, supported by strong signals from key indicators such as MACD, Bollinger Bands, and moving averages. This technical evolution, coupled with robust price performance relative to the Sensex, reinforces a positive outlook for this mid-cap pharmaceutical player."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4032941",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IpcaLaboratorie_technicaldot_4032941.png",
        "date": "2026-06-03 08:04:59",
        "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, the stock’s technical indicators present a nuanced picture, reflecting a blend of bullish and bearish signals that investors should carefully analyse."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-4029692",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IpcaLaboratorie_technicaldot_4029692.png",
        "date": "2026-06-02 08:08:10",
        "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators reveal a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, prompting a downgrade in its Mojo Grade from Buy to Hold as of 29 May 2026."
      },
      {
        "title": "Ipca Laboratories Ltd Valuation Shifts to Fair Amidst Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-valuation-shifts-to-fair-amidst-sector-comparisons-4029424",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IpcaLaboratorie_valuationdot_4029424.png",
        "date": "2026-06-02 08:04:21",
        "description": "Ipca Laboratories Ltd has recently undergone a notable change in its valuation parameters, shifting from an expensive to a fair valuation grade. This adjustment reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the mid-cap pharmaceutical player differently against its peers and historical benchmarks."
      },
      {
        "title": "Ipca Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4025571",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IpcaLaboratorie_mojoScore_4025571.png",
        "date": "2026-06-01 08:17:09",
        "description": "Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 29 May 2026. This adjustment reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technical indicators. While the company continues to demonstrate solid fundamentals and consistent returns, evolving market dynamics and technical signals have prompted a more cautious stance."
      }
    ],
    "total": 978,
    "sid": "950228",
    "stock_news_url": "https://www.marketsmojo.com/news/ipca-laboratories-950228"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "12-Jun-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Jun-2026",
      "details": "Eclsoed copy of newspapers",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "04-Jun-2026",
      "details": "Transcript of Conference Call held on 1st June 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 05 Aug 25",
          "dt": "2025-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22",
          "dt": "2022-01-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ipca Laboratories Ltd is Rated Buy

2026-06-20 10:10:29

Ipca Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 8 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 20 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Ipca Laboratories Gains 8.60%: 5 Key Factors Driving the Week’s Momentum

2026-06-13 16:24:58

Key Events This Week

1 June: Downgrade to Hold amid mixed technical and valuation signals

2 June: Valuation shifts to fair relative to sector peers

3 June: Technical momentum shifts to mildly bullish stance

4 June: Strong price gains on heavy volume (+4.23%)

5 June: Week closes at ₹1,643.05, up 8.60% for the week

Week Open

Rs.1,512.90

...

Read full news article

Ipca Laboratories Declines 3.48% Despite Technical Upgrade: 5 Key Insights

2026-06-13 11:05:52

Key Events This Week

8 June: MarketsMOJO upgrades Ipca Laboratories Ltd to Buy on strong technical and financial performance

9 June: Technical momentum shifts signal bullish outlook amid price near 52-week high

11 June: Heavy volume selling leads to 1.30% price decline

12 June: Week closes at ₹1,585.80, down 3.48% for the week

Week Open

₹1,643.05

<...

Read full news article

Ipca Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-06-09 08:50:00

Ipca Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial metrics, valuation, and overall quality. This upgrade, effective from 8 June 2026, is underpinned by robust quarterly results, bullish technical trends, and favourable long-term returns that outpace the broader market.

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-09 08:03:11

Ipca Laboratories Ltd has demonstrated a notable shift in technical momentum, upgrading its trend from mildly bullish to bullish, supported by strong signals from key indicators such as MACD, Bollinger Bands, and moving averages. This technical evolution, coupled with robust price performance relative to the Sensex, reinforces a positive outlook for this mid-cap pharmaceutical player.

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-03 08:04:59

Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, the stock’s technical indicators present a nuanced picture, reflecting a blend of bullish and bearish signals that investors should carefully analyse.

Read full news article

Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-02 08:08:10

Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators reveal a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, prompting a downgrade in its Mojo Grade from Buy to Hold as of 29 May 2026.

Read full news article

Ipca Laboratories Ltd Valuation Shifts to Fair Amidst Sector Comparisons

2026-06-02 08:04:21

Ipca Laboratories Ltd has recently undergone a notable change in its valuation parameters, shifting from an expensive to a fair valuation grade. This adjustment reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the mid-cap pharmaceutical player differently against its peers and historical benchmarks.

Read full news article

Ipca Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-06-01 08:17:09

Ipca Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 29 May 2026. This adjustment reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technical indicators. While the company continues to demonstrate solid fundamentals and consistent returns, evolving market dynamics and technical signals have prompted a more cautious stance.

Read full news article

View All News